Literature DB >> 22907142

In vitro differentiation of adult adipose mesenchymal stem cells into retinal progenitor cells.

Gustavo A Moviglia1, Nahuel Blasetti, Jorge O Zarate, David E Pelayes.   

Abstract

INTRODUCTION: It has been previously shown that adult mesenchymal stem cells (MSCs) differentiate into neural progenitor cells (NPCs) and that the differentiation process was completed in 24-48 h. In this previous study, MSCs from a bone marrow or fat source were co-incubated with homologous autoaggressive cells (ECs) against nerve tissue, and these NPCs were successfully used in human regenerative therapeutic approaches. The present study was conducted to investigate whether a similar differentiation method could be used to obtain autologous retinal progenitor cells (RPCs).
METHODS: Human Th1 cells against retinal tissue were obtained by challenging human blood mononuclear cells with an eye lysate of bovine origin; negative selection was performed using a specific immunomagnetic bead cocktail. Fat MSCs were obtained from a human donor through mechanical and enzymatic dissociation of a surgical sample. The ECs and MSCs were co-cultured in a serum-free medium without the addition of cytokines for 0, 24, 48 and 72 h. The plastic adherent cells were morphologically examined using inverted-phase microscopy and characterized by immunofluorescent staining using antibodies against Pax 6, TUBB3, GFAP, Bestrophin 2, RPE 65, OPN1 SW, and rhodopsin antigens.
RESULTS: The early signs of MSC differentiation into RPCs were observed at 24 h of co-culture, and the early differentiated retinal linage cells appeared at 72 h (neurons, rods, Müller cells, retinal ganglion cells and retinal pigmented epithelial cells). These changes increased during further culture.
CONCLUSION: The results reported here support the development of a method to obtain a large number of autologous adult RPCs, which could be used to treat different retinopathies.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907142     DOI: 10.1159/000339839

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  10 in total

1.  Thermally labile components of aqueous humor potently induce osteogenic potential in adipose-derived mesenchymal stem cells.

Authors:  Joshua T Morgan; Heung Sun Kwon; Joshua A Wood; Dori L Borjesson; Stanislav I Tomarev; Christopher J Murphy; Paul Russell
Journal:  Exp Eye Res       Date:  2015-02-24       Impact factor: 3.467

Review 2.  Current focus of stem cell application in retinal repair.

Authors:  María L Alonso-Alonso; Girish K Srivastava
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

3.  Generation of Retinal Pigmented Epithelium-Like Cells from Pigmented Spheres Differentiated from Bone Marrow Stromal Cell-Derived Neurospheres.

Authors:  Hamid Aboutaleb Kadkhodaeian; Taki Tiraihi; Hamid Ahmadieh; Hossein Ziaei; Narsis Daftarian; Taher Taheri
Journal:  Tissue Eng Regen Med       Date:  2019-05-03       Impact factor: 4.169

4.  Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD.

Authors:  Ajay E Kuriyan; Thomas A Albini; Justin H Townsend; Marianeli Rodriguez; Hemang K Pandya; Robert E Leonard; M Brandon Parrott; Philip J Rosenfeld; Harry W Flynn; Jeffrey L Goldberg
Journal:  N Engl J Med       Date:  2017-03-16       Impact factor: 91.245

Review 5.  Dual differentiation-exogenous mesenchymal stem cell therapy for traumatic spinal cord injury repair in a murine hemisection model.

Authors:  Hai Liu; Edward M Schwarz; Chao Xie
Journal:  Stem Cells Int       Date:  2013-08-20       Impact factor: 5.443

Review 6.  Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.

Authors:  P Fernández-Robredo; A Sancho; S Johnen; S Recalde; N Gama; G Thumann; J Groll; A García-Layana
Journal:  J Ophthalmol       Date:  2014-01-14       Impact factor: 1.909

7.  Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study.

Authors:  Ayse Oner; Z Burcin Gonen; Neslihan Sinim; Mustafa Cetin; Yusuf Ozkul
Journal:  Stem Cell Res Ther       Date:  2016-12-01       Impact factor: 6.832

8.  Choice of Cell Source in Cell-Based Therapies for Retinal Damage due to Age-Related Macular Degeneration: A Review.

Authors:  Sudhakar John; Sundaram Natarajan; Periyasamy Parikumar; Mahesh Shanmugam P; Rajappa Senthilkumar; David William Green; Samuel J K Abraham
Journal:  J Ophthalmol       Date:  2013-04-22       Impact factor: 1.909

9.  Gender difference in the neuroprotective effect of rat bone marrow mesenchymal cells against hypoxia-induced apoptosis of retinal ganglion cells.

Authors:  Jing Yuan; Jian-Xiong Yu
Journal:  Neural Regen Res       Date:  2016-05       Impact factor: 5.135

10.  Recent Advances in Retinal Stem Cell Therapy.

Authors:  Sujoy Bhattacharya; Rajashekhar Gangaraju; Edward Chaum
Journal:  Curr Mol Biol Rep       Date:  2017-07-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.